Kaixin Certification Invited to Training Conference Hosted by EXCIPACT Asbl in China Region
On September 3, 2025, the "EXCIPACT-IPEC CHINA-SPPEA Joint Pharmaceutical Excipients GMP and Risk Assessment Training Conference" was held at the Xuanwu Hotel in Nanjing, hosted by EXCiPACT asbl and co organized by the International Pharmaceutical Excipients Association (China) and the Jiangsu Pharmaceutical Packaging Pharmaceutical Excipients Association. Kaixin Certification was invited to attend the training conference.
At the meeting, Iain Moore, Senior Consultant of EXCiPACT, gave a comprehensive presentation on the establishment and revision of EXCiPACT GMP. He also introduced EXCiPACT as an independent third-party certification system, with patient safety at its core and risk assessment covering the entire supply chain, including GMP (including China NMPA GMP Appendix), GDP, and GWP. Through this certification, companies can provide users with annual evidence of GMP/GDP/GWP implementation, enhancing mutual trust and reducing the burden of multi-party audits. Its independent supervision mechanism also ensures the transparency and reliability of the certification.
Alain Becart, Quality Manager of EXCiPACT, gave a presentation on how to use EXCiPACT as an auxiliary material supplier management tool, with a focus on the application of EXCiPACT certification in supplier qualification certification. The certification process consists of two main steps: first, determine the required GMP level based on a formal risk assessment (FRA), classify risks based on relevant technical reports, and select an appropriate GMP system; Subsequently, EXCiPACT qualification certification will be conducted.
The participation of Kaixin Certification in the "EXCIPACT-IPEC CHINA-SPPEA Joint Pharmaceutical excipient GMP and Risk Assessment Training Conference" is a learning and exchange experience that focuses on the core of the industry and combines depth and practical value.
At the meeting, relevant experts interpreted the GMP standards for pharmaceutical excipients, accurately benchmarking the core points of current industry compliance requirements, allowing us to have a clearer understanding of the key links and execution details in the process of implementing the standards. The sharing of risk assessment topics, through practical case analysis, provides us with a more systematic approach to risk identification, analysis, and control. It also makes us realize the importance of dynamic and refined risk prevention and control in the full chain management of pharmaceutical excipients.
In the process of communicating with industry colleagues, we not only learned about the experience and practices of different enterprises in compliance practice and risk response, but also felt the common pursuit of high-quality development in the entire pharmaceutical excipient industry. In the future, Kaixin Certification will integrate the knowledge and understanding gained from this conference into the certification work practice, further enhancing its service capabilities in the field of pharmaceutical excipients. At the same time, we also look forward to working with more industry partners to promote the standardized and standardized development of the pharmaceutical excipient industry and lay a solid foundation for drug safety.
About Kaixin Certification
Kaixin Certification is a third-party certification body accredited by CNAS and ANAB. Focusing on providing certification services covering quality and safety, agri-food products, intellectual property, information security, energy, and sustainability, Kaixin has served over 20,000 clients, and remains committed to delivering premium and efficient service to clients, contributing to economic prosperity, environmental sustainability, and social responsibility.